Who owns Mereo Biopharma Group Plc ads?
- Ticker: MREO
- CUSIP Number: 589492107
Tip: Access positions for across all investors
Analyze quarterly positions in Mereo Biopharma Group Plc ads with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mereo Biopharma Group Plc ads stock
Who bought or sold Mereo Biopharma Group Plc ads this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rubric Capital Management | 15M | $55M | 13% | Jun 2024 |
|
| Rock Springs Capital Management | 9.3M | $33M | 14% | Jun 2024 |
|
| Henderson Group | 7.9M | $28M | 54% | Jun 2024 |
|
| Deerfield Management Company | 6.7M | $24M | 100% | Jun 2024 |
|
| 683 Capital Management | 5.0M | $18M | -13% | Jun 2024 |
|
| Frazier Life Sciences Management | 4.4M | $16M | 100% | Jun 2024 |
|
| Clearline Capital | 3.3M | $12M | 0% | Jun 2024 |
|
| Millennium Management | 3.2M | $12M | 47% | Jun 2024 |
|
| Goldman Sachs Group | 2.5M | $9.0M | 12% | Jun 2024 |
|
| Renaissance Technologies | 1.8M | $6.3M | 5% | Jun 2024 |
|
| Perceptive Advisors | 1.3M | $4.5M | 100% | Jun 2024 |
|
| Soleus Capital Management | 1.2M | $4.5M | -52% | Jun 2024 |
|
| Marshall Wace | 1.1M | $4.1M | 100% | Jun 2024 |
|
| Susquehanna International | 1.0M | $3.7M | -45% | Jun 2024 |
|
| Blue Owl Capital Holdings | 898k | $3.2M | 100% | Jun 2024 |
|
| Citadel Advisors | 537k | $1.9M | 260% | Jun 2024 |
|
| Artia Global Partners | 421k | $1.5M | 0% | Jun 2024 |
|
| Monaco Asset Management SAM | 348k | $1.3M | -14% | Jun 2024 |
|
| Cantor Fitzgerald, L. P. | 275k | $990k | 100% | Jun 2024 |
|
| Knoll Capital Management | 261k | $938k | 0% | Jun 2024 |
|
| Knott David M Jr | 236k | $850k | 687% | Jun 2024 |
|
| J. Goldman & Co | 228k | $820k | -18% | Jun 2024 |
|
| Verition Fund Management | 227k | $815k | -53% | Jun 2024 |
|
| Morgan Stanley | 208k | $831k | -85% | Jun 2024 |
|
| Two Sigma Investments | 202k | $726k | -43% | Jun 2024 |
|
| Polar Securities | 146k | $525k | 100% | Jun 2024 |
|
| Geode Capital Management | 92k | $332k | -5% | Jun 2024 |
|
| Jane Street | 85k | $305k | -3% | Jun 2024 |
|
| Bank of America Corporation | 84k | $303k | 7% | Jun 2024 |
|
| Suvretta Capital Management | 75k | $270k | -98% | Jun 2024 |
|
| Standard Life Aberdeen | 73k | $263k | -91% | Jun 2024 |
|
| PRIMECAP Management Company | 54k | $194k | 0% | Jun 2024 |
|
| Fred Alger Management | 49k | $178k | -75% | Jun 2024 |
|
| Clear Harbor Asset Management | 44k | $157k | -5% | Jun 2024 |
|
| Simplex Trading | 41k | $149k | 42% | Jun 2024 |
|
| Forefront Analytics | 36k | $130k | -17% | Jun 2024 |
|
| Qube Research & Technologies | 33k | $120k | -70% | Jun 2024 |
|
| Hsbc Holdings | 29k | $100k | 0% | Jun 2024 |
|
| Squarepoint Ops | 27k | $98k | -43% | Jun 2024 |
|
| Centiva Capital | 25k | $90k | 0% | Jun 2024 |
|
| Advisors Preferred | 25k | $90k | 200% | Jun 2024 |
|
| Golden State Equity Partners | 25k | $89k | 100% | Jun 2024 |
|
| Bnp Paribas Arbitrage, Snc | 21k | $74k | 18% | Jun 2024 |
|
| Resources Investment Advisors | 18k | $66k | -1% | Jun 2024 |
|
| PFG Investments | 17k | $61k | -46% | Jun 2024 |
|
| BlackRock | 17k | $61k | -49% | Jun 2024 |
|
| Manufacturers Life Insurance Company | 15k | $53k | -88% | Jun 2024 |
|
| Virtu Financial | 14k | $51k | 100% | Jun 2024 |
|
| Two Sigma Securities | 14k | $50k | 100% | Jun 2024 |
|
| Adviser Investments | 13k | $45k | 100% | Jun 2024 |
|
| Newbridge Financial Services Group | 12k | $42k | 0% | Jun 2024 |
|
| Level Four Advisory Services | 10k | $36k | -50% | Jun 2024 |
|
| Rhumbline Advisers | 7.0k | $25k | 71% | Jun 2024 |
|
| GAMMA Investing | 6.8k | $24k | 13% | Jun 2024 |
|
| Pnc Financial Services | 4.5k | $16k | 100% | Jun 2024 |
|
| SRS Capital Advisors | 4.0k | $14k | 0% | Jun 2024 |
|
| Ariadne Wealth Management | 3.5k | $260k | 100% | Jun 2024 |
|
| Lindbrook Capital | 1.7k | $6.0k | -28% | Jun 2024 |
|
| Hanson McClain Advisors | 1.5k | $5.8k | 0% | Jun 2024 |
|
| BFSG | 1.0k | $3.6k | 0% | Jun 2024 |
|
| Signature | 679.00 | $2.4k | -17% | Jun 2024 |
|
| Quadrant Capital | 398.00 | $1.4k | -46% | Jun 2024 |
|
| Jpmorgan Chase & Co | 365.00 | $1.3k | -99% | Jun 2024 |
|
| New England Capital Financial Advisors | 300.00 | $1.1k | 0% | Jun 2024 |
|
| Wells Fargo & Company | 230.00 | $825.999000 | 0% | Jun 2024 |
|
| Plante Moran Financial Advisors | 48.00 | $173.001600 | 0% | Jun 2024 |
|
| Barclays | 38.00 | $0 | 0% | Jun 2024 |
|
| Royal Bank of Canada | 28.00 | $0 | 0% | Jun 2024 |
|
| Us Bancorp | 13.00 | $47.000200 | -97% | Jun 2024 |
|
Who sold out of Mereo Biopharma Group Plc ads?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| T. Rowe Price Associates | Mar 2024 | 992k | $3.3M |
| EAM Global Investors | Mar 2024 | 195k | $644k |
| TD Asset Management | Mar 2024 | 148k | $488k |
| Jump Financial | Mar 2024 | 127k | $418k |
| GSA Capital Partners | Mar 2024 | 76k | $250k |
| Envestnet Asset Management | Mar 2024 | 56k | $185k |
| Cubist Systematic Strategies | Mar 2024 | 47k | $155k |
| Index Fund Advisors | Mar 2024 | 30k | $99k |
| Total Clarity Wealth Management | Mar 2024 | 12k | $39k |
| Tower Research Capital | Mar 2024 | 7.1k | $24k |
| Point72 Asset Management | Mar 2024 | 1.9k | $6.3k |
| ICA Group Wealth Management | Mar 2024 | 1.0k | $3.3k |